GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Boston Scientific Corp (WBO:BSXC) » Definitions » Book Value per Share

Boston Scientific (WBO:BSXC) Book Value per Share : €12.66 (As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Boston Scientific Book Value per Share?

Boston Scientific's book value per share for the quarter that ended in Sep. 2024 was €12.66.

During the past 12 months, Boston Scientific's average Book Value Per Share Growth Rate was 9.00% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 6.70% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 13.30% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 13.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Boston Scientific was 54.00% per year. The lowest was -14.70% per year. And the median was 12.70% per year.

Boston Scientific's current price is €86.50. Its book value per share for the quarter that ended in Sep. 2024 was €12.66. Hence, today's PB Ratio of Boston Scientific is 6.83.

During the past 13 years, the highest P/B Ratio of Boston Scientific was 6.87. The lowest was 2.60. And the median was 4.27.

Warning Sign:

Boston Scientific Corp stock PB Ratio (=6.41) is close to 10-year high of 6.87


Boston Scientific Book Value per Share Historical Data

The historical data trend for Boston Scientific's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Boston Scientific Book Value per Share Chart

Boston Scientific Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Book Value per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.95 8.89 10.32 11.57 12.06

Boston Scientific Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.08 12.06 12.47 12.87 12.66

Competitive Comparison of Boston Scientific's Book Value per Share

For the Medical Devices subindustry, Boston Scientific's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Boston Scientific's PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Boston Scientific's PB Ratio distribution charts can be found below:

* The bar in red indicates where Boston Scientific's PB Ratio falls into.



Boston Scientific Book Value per Share Calculation

Boston Scientific's Book Value Per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(17,681-0)/1,466
=12.06

Boston Scientific's Book Value Per Share for the quarter that ended in Sep. 2024 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(18,658-0)/1,473
=12.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


Boston Scientific  (WBO:BSXC) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Boston Scientific Book Value per Share Related Terms

Thank you for viewing the detailed overview of Boston Scientific's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Boston Scientific Business Description

Address
300 Boston Scientific Way, Marlborough, MA, USA, 01752-1234
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

Boston Scientific Headlines

No Headlines